Genetic epidemiology of differences in low-density lipoprotein (LDL) cholesterol concentration: Possible involvement of variation at the apolipoprotein B gene locus in LDL kinetics

Genetic Epidemiology

Volumn 7, Issue 3, 1990, Pages 199-210

  Houlston, R S ^a,b   Turner, P R ^a,c   Lewis, B ^a   Humphries, S E ^b  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

apo B; restriction fragment length polymorphisms (RFLPs)

Indexed keywords

APOLIPOPROTEIN B; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; GENE LOCUS; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; AFRICA; APOLIPOPROTEINS B; BLOTTING, SOUTHERN; CHROMOSOME MAPPING; FEMALE; FINLAND; GREAT BRITAIN; HUMAN; ITALY; LIPOPROTEINS, LDL CHOLESTEROL; MALE; MIDDLE AGE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SPAIN; SUPPORT, NON-U.S. GOV'T; VARIATION (GENETICS);

EID: 0025000896     PISSN: 07410395     EISSN: 10982272     Source Type: Journal    
DOI: 10.1002/gepi.1370070304     Document Type: Article

References (49)

1. XbaI and c/g polymorphisms of the apolipoproteins B gene locus are associated with serum cholesterol and LDL-cholesterol levels in Finland
2. The isolation of genomic recombinants for the human apolipoprotein B gene, and the mapping of three common DNA polymorphisms of the gene—A useful marker for human chromosome 2
3. Genetics of Coronary heart disease
4. DNA polymorphism at the apolipoprotein B locus is associated with lipoprotein level
5. Bias of the contribution of single-locus effects to the variance of a quantitative trait
6. Lipoprotein metabolism in the macrophage. Implications for cholesterol deposition in atherosclerosis
7. Analysis of the human apolipoprotein B gene Complete structure of the B-74 region
8. Cloned human apolipoprotein B cDNA detects a 20,000 bases long mRNA
9. Apolipoprotein E polymorphism and atheroscherosis
10. Catabolic rate of low density lipoprotein is influenced by variation in the apolipoprotein B gene
11. Relationships between DNA and protein polymorphisms of apolipoprotein B
12. Serum apolipoprotein AI and B and lipoproteins in middle aged men with and without previous myocardial infarction
13. Genetic and cultural inheritance of serum lipids, low density and high density lipoprotein cholesterol and serum lipoproteins AI, AII and B
14. Major locus inheritance of apolipoprotein B in Utah pedigrees
15. Apolipoprotein-B gene polymorphisms associated with myocardial infarction
16. The fractional catabolic rate of low density lipoprotein in normal individuals is influenced by variation in the apolipoprotein B gene: A preliminary study
17. Metabolic epidemiology of plasma cholesterol within populations and between populations
18. Quantitative studies of very low density lipoprotein conversion to low density lipoprotein in normal controls and primary hyperlipidaemic states and the role of direct secretion of low density lipoprotein in heterozygous familial hypercholesterolaemia
19. A study of DNA polymorphisms around the human apolipoprotein AI gene in hyperlipidaemia and normal individuals
20. A PvuII polymorphism, in the 5′ flanking region of the apo AIV gene: Detection of genetic variation determining apo AI and HDL-cholesterol concentration
21. Human apolipoprotein B: Complete cDNA sequence and identification of structural domains of the protein
22. Common DNA polymorphism within coding sequence of apolipoprotein B gene associated with altered lipid levels
23. The lipoproteins: Preditors, protectors and pathogens
24. Frequency of risk factors for ischaemic heart disease in a healthy British population with particular reference to serum lipoprotein levels
25. The L.R.C. coronary primary prevention trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering
26. Cloning and expression of apolipoprotein B, the major protein of low and very low density lipoproteins
27. Two DNA restriction fragment length polymorphisms associated with Ag(tz) and Ag(cg) antigenic sites of human apolipoprotein B
28. Analysis of genetic and environmental sources of variation in serum cholesterol in Techumseh, Michigan V. Variance components estimated from pedigrees
29. Total and cardiovascular mortality in relation to cigarette smoking, serum cholesterol concentration and diastolic blood pressure among black and white males followed for five years
30. Sources of individual variation in the quantitative levels of apolipoprotein B in pedigrees ascertained through a lipid clinic
31. RFLP for the human apolipoprotein B gene
32. Cultural and biological determinants of lipoprotein concentrations
33. Molecular cloning of human LDL apolipoprotein B cDNA evidence for more than one gene per haploid genome
34. Analysis of genetic and environmental sources of variation in serum cholesterol Tecumseh, Michigan IV. Separation of polygene from common environmental effects
35. Association of coronary atherosclerosis with hyperapobetalipoproteinaemia (increased protein but normal cholesterol levels in human plasma low density lipoproteins)
36. Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B100
37. Apolipoprotein B and lipoprotein metabolism
38. Apolipoprotein B gene variants are involved in the determination of serum cholesterol levels: A study in normo- and hyperlipidaemic individuals
39. Metabolic study of variation in plasma cholesterol level in normal men
40. Familial defective apolipoprotein B100. Detection in the United Kingdom and Scandanavia and clinical characteristics of ten cases
41. In vivo evidence for reduced binding of low density lipoproteins to receptors as a cause of primary moderate hypercholesterolaemia
42. Heritability of low density lipoprotein receptor activity of human blood mononuclear cells: Studies in normolipidaemic adult male twins
43. Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E
44. Plasma apolipoprotein B and VLDL-LDL- and HDL-cholesterol as risk factors in the development of coronary arterial disease in male patients examined by angiography